Clinical Trial Update: A Study of Brivaracetam in Subjects With Partial Onset Seizures [Phase 2]

View source ↗

Summary

This report covers the completion of a Phase 2 trial evaluating Brivaracetam in subjects with focal epilepsy presenting partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• Brivaracetam (Briviact) (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Focal | Phase 2 | Status: COMPLETED